HTG Molecular Diagnostics
Financial ratios & Valuation

Historical Multiples (2013 – 2022)

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-56.17-47.36-132.57-88.11-163.38-611.83-1.38-1.06-2.19-0.16-0.05-163.38
Price/Sales ratio
294.73198.59701.92447.01209.88468.141.392.594.220.550.48468.14
Price/Book Value ratio
-29.44-27.49167.92-410.23-1.01K477.281.111.533.610.650.18-1.01K
Price/Cash Flow ratio
-55.91-50.86-147.42-103.19-186.92-764.16-1.60-1.36-2.27-0.19-0.06-186.92
Price/Free Cash Flow ratio
-52.46-47.71-137.83-94.88-176.08-712.78-1.50-1.32-2.19-0.19-0.06-176.08
Price/Earnings Growth ratio
-7.14-2.541.493.893.199.19-0.000.020.040.000.009.19
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-0.17%3.72%17.47%19.42%66.31%76.32%53.59%53.30%54.02%28.18%-95.89%76.32%
Operating Profit Margin
-531.21%-385.97%-467.39%-474.04%-120.07%-75.14%-98.73%-229.10%-200.11%-327.18%-1112.80%-75.14%
Pretax Profit Margin
-524.70%-419.30%-529.18%-507.12%-128.43%-76.49%-100.47%-243.95%-192.24%-339.03%-864.90%-76.49%
Net Profit Margin
-524.70%-419.30%-529.44%-507.32%-128.45%-76.51%-100.48%-244.12%-192.49%-339.20%-865.31%-76.51%
Effective Tax Rate
N/A2.88%-0.04%-0.03%-0.01%-0.02%-0.01%-0.06%-0.13%-0.05%-0.04%-0.02%
Return on Assets
-267.61%-159.92%-54.24%-141.10%-89.19%-37.59%-42.77%-59.29%-56.28%-121.46%-191.14%-37.59%
Return On Equity
52.42%58.06%-126.66%465.58%619.70%-78.01%-80.50%-144.08%-164.86%-400.51%-477.81%-78.01%
Return on Capital Employed
-588.48%-236.84%-57.02%-288.51%-223.93%-43.96%-52.34%-70.04%-86.87%-219.09%-557.80%-43.96%
Liquidity Ratios
Current Ratio
N/AN/A5.511.511.345.414.644.54N/AN/A1.571.34
Quick Ratio
1.011.375.161.351.255.224.504.332.531.781.371.25
Cash ratio
0.761.090.520.740.741.200.853.090.961.471.220.74
Days of Sales Outstanding
98.2687.8364.6897.95157.1885.0860.1467.8385.7481.51132.14132.14
Days of Inventory outstanding
120.88168.00240.88133.3586.6693.6852.00136.44177.1772.5951.5293.68
Operating Cycle
219.14255.84305.57231.30243.85178.77112.14204.27262.92154.1084.10178.77
Days of Payables Outstanding
121.87108.0179.3167.21179.04132.6468.09123.33147.0292.4093.46132.64
Cash Conversion Cycle
97.27147.83226.25164.0864.8146.1244.0480.94115.9061.7051.3846.12
Debt Ratios
Debt Ratio
0.011.280.270.630.410.220.240.350.380.271.120.41
Debt Equity Ratio
-0.00-0.460.64-2.10-2.860.450.460.871.120.891.92-2.86
Long-term Debt to Capitalization
-0.00-0.760.31-26.45-29.970.310.230.380.370.090.37-29.97
Total Debt to Capitalization
-0.00-0.870.391.901.530.310.310.460.520.470.520.52
Interest Coverage Ratio
N/AN/A-10.98-13.02-13.55-17.91-19.80-19.11N/AN/A-32.50-17.91
Cash Flow to Debt Ratio
-267.97-1.15-1.77-1.88-1.89-1.36-1.48-1.28-1.40-3.80-2.57-1.36
Company Equity Multiplier
-0.19-0.362.33-3.29-6.942.071.882.432.923.291.70-6.94
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-5.27-3.90-4.76-4.33-1.12-0.61-0.86-1.90-1.85-2.89-7.68-0.61
Free Cash Flow / Operating Cash Flow Ratio
1.061.061.061.081.061.071.061.021.031.001.001.07
Cash Flow Coverage Ratio
-267.97-1.15-1.77-1.88-1.89-1.36-1.48-1.28-1.40-3.80-2.57-1.36
Short Term Coverage Ratio
N/A-15.97-6.29-3.47-2.86N/A-4.45-4.39-2.95-4.29-5.41N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A